Fangzhou Inc. Garners Industry Recognition as an Innovator in AI Technology

GUANGZHOU, China, Oct. 30, 2024 /PRNewswire/ — Fangzhou Inc. (“Fangzhou”) (06086.HK), a leader in Internet healthcare solutions, was featured on the 2024 Guangdong “AI Catalyst” Enterprise Billboard at the 2024 Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence Industry Conference. The Company was selected for its significant contributions in advancing the use of AI technology in the field of online healthcare and chronic disease management. Fangzhou’s platform leverages advanced technologies, including AI assistants and big data, with the goal of enhancing the efficiency of its chronic disease management services and providing patients and doctors with a better user experience.

Mr. Xie Fangmin, CEO of Fangzhou, stated, “We are honored to be recognized as an AI technology innovator. This acknowledgment reflects our commitment to improving healthcare through technological advancement and our dedication to providing exceptional service to patients and healthcare providers alike.”

Guangdong at the Forefront of AI Integration

Guangdong has consistently demonstrated its commitment to fostering AI applications across a range of industries and sectors. In May, it introduced the “Measures for Empowering Various Industries with Artificial Intelligence,” aiming to create over 500 AI-driven application scenarios in areas like manufacturing, education, and senior care. This effort continued in October with the “Action Plan for Promoting High-Quality Development of Guangdong’s Life Sciences Industry,” outlining 38 measures to position Guangdong as a leading biotech hub.

About Fangzhou Inc.

Fangzhou Inc. (06086.HK) is China’s leading online chronic disease management platform. With 45.6 million registered users and 217,000 registered doctors on its platform (as of June 30, 2024), the Company provides tailored medical care and precision medicine for a growing population of chronic disease patients. For more details, visit https://investors.jianke.com.

About the Greater Bay Area Artificial Intelligence Industry Conference

The 2024 Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence Industry Conference was held on October 23rd in Nansha, Guangzhou. Under the leadership of the Guangdong Province Department of Science and Technology, the event was organized by the Guangdong Association of Artificial Intelligence Industry, with support from the Smart Manufacturing Committee of the Chinese Association for Artificial Intelligence and Guangzhou University. The conference gathered 11 prominent academicians and over 1,000 leaders from academia and industry to explore AI trends and technological advancements.

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements

Media Contact
For further inquiries or interviews, please reach out to:
Xingwei Zhao Associate Director of Public Relations Email: pr@jianke.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/fangzhou-inc-garners-industry-recognition-as-an-innovator-in-ai-technology-302292293.html

SOURCE Fangzhou Inc.

Staff

Recent Posts

Nihon Kohden Introduces First-Ever ATO-Certified Ventilators

IRVINE, Calif.--(BUSINESS WIRE)--#RespiratoryCare--Nihon Kohden, a global leader in medical technology, today announced the introduction of…

5 hours ago

2025 Medicare Physician Fee Schedule Final Rule Includes Two Major Wins for Therapy Providers

APTA advocacy leads to impactful policy wins that will reduce administrative burden, improve access, and…

5 hours ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTON, Mass., Nov. 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical…

5 hours ago

Gestalt and Paige Partner to Enhance Digital Pathology Workflows with Integration of Advanced AI Algorithms

SPOKANE, Wash. and NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Gestalt, a leader in digital pathology…

5 hours ago

Wasatch BioLabs and Oxford Nanopore Team Up to Accelerate Methylation Sequencing Towards Clinical Use

SALT LAKE CITY and OXFORD, United Kingdom, Nov. 1, 2024 /PRNewswire/ -- Wasatch Biolabs (WBL),…

5 hours ago

The 2024 Presidential Election: What Could It Mean for Your Financial Plan?

With the upcoming election, individuals must brace for potential economic shifts and policy changes that…

5 hours ago